Claims could total up to $4 bln, record for shipping...
Category:
Non-Life
Latest
Titanic Law helps ship owner limit bridge collapse liability
A key to determining any insurance claims will be proving whether...
SEC ramps up hack probe with focus on tech, telecom companies
The probe — aimed partly at determining what the companies may have...
India records less than 20,000 fresh COVID-19 cases; no. of recoveries goes past 99 lakh
The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.
There are 2,50,183 active coronavirus cases in the country, which accounts for 2.43 per cent of the total caseload, the data stated.
SolarWinds hackers accessed Microsoft source code, the company says
The SolarWinds hack is among the most ambitious cyber operations ever disclosed, compromising at least half-a-dozen federal agencies and potentially thousands of companies and other institutions. U.S. and private sector investigators have spent the holidays combing through logs to try to understand whether their data has been stolen or modified.
Most prioritised beneficiaries will get vaccine free of cost In the first phase of vaccination: Harsh Vardhan
Earlier in the day, the Health Minister had said that the vaccine will be free across the country. “Not just in Delhi, it will be free across the country,” Vardhan said when asked for the government’s position on the issue.
Britain will allow mixing of COVID-19 vaccines on rare occasions
Mary Ramsay, head of immunisations at Public Health England, said this would only happen on extremely rare occasions, and that the government was not recommending the mixing of vaccines, which require at least two doses given several weeks apart.
Finland confirms first adverse reaction to Pfizer/BioNTech COVID-19 vaccine
“When there are at least five such reports, we will put information on our website about the type of reactions that have occurred,” the agency’s Chief Physician Maija Kaukonen told the broadcaster, adding that no further details could be disclosed due to patient confidentiality.
Accidental death insurance cover for Delhi Police personnel raised to ₹78 lakh
Delhi Police Commissioner S.N. Shrivastava said that the Delhi Police negotiated a better insurance claim structure with Axis Bank, therefore, insurance cover for natural deaths has been raised from Rs 5 lakh to Rs 28 lakh and from Rs 30 lakh to Rs 78 lakh for accidental death. Apart from this, the family of the cop will be compensated with Rs 10 lakh if he commits suicide.
India drug regulator approves AstraZeneca COVID vaccine, country’s first
Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.
The Central Drugs Standard Control Organization is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.
WHO emergency COVID-19 vaccine listing aims to lift access in poor countries
The United Nations health agency said it will work with regional partners to tell national health authorities about the two-dose shot and its anticipated benefits.
The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like COVID-19, which otherwise could lead to delays.
Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk
President-elect Biden has also vowed to reduce drug costs and to allow Medicare, a U.S. government health insurance program, to negotiate drug prices. He has support from Congressional Democrats to pass such legislation, which the Congressional Budget Office has said could cost the industry more than $300 billion by 2029.
BioNTech founders warn of vaccine supply gaps – Spiegel
“At the moment it doesn’t look good – a hole is appearing because there’s a lack of other approved vaccines and we have to fill the gap with our own vaccine,” BioNTech CEO Ugur Sahin told news weekly Spiegel.